Jae Won Lee is the founder of Ticaros. Ticaros has raised $9M in total funding. Latest round: Series B. Based in Seoul, South Korea.
Jae Won Lee is the CEO of TiCARos, a biotech company that specializes in developing next-generation immunotherapeutics for cancers. The company leverages accumulated experiences and technologies from immunologists at Seoul National University, College of Medicine. TiCARos aims to create breakthroughs in treating both hematologic malignancies and advanced solid tumors.
Full founder directory · Investor directory · Company funding database · Fundraising library